Steve K Barbarick
CIK 1559824 · President & COO · last filed 2021-10-19
Steve K Barbarick is a President & COO who has filed 44 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for STAB, was dated Oct 19, 2021. Across all open-market trades the lifetime net is −$32.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TSCO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
5401 VIRGINIA WAY
BRENTWOOD, TN 37027
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Statera Biopharma, Inc. (STAB) Delisted | Director | 60,000 | $0.00 | $6 | $0 | 1 | 2021-10-19 |
| At Home Group Inc. (HOME) Delisted | Director | 40,066 | $36.99 | $1.48M | $198.8K | 5 | 2021-04-01 |
| TSCO | President & COO | 219,680 | $33.26 | $7.31M | -$33.02M | 37 | 2019-06-19 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-19 | Statera Biopharma, Inc. (STAB) Delisted | Grant (A) | +60,000 | $0 | EDGAR |
| 2021-08-03 | — | Mixed | −40,066 | -$1.48M | |
| 2021-04-01 | At Home Group Inc. (HOME) Delisted | Grant (A) | +5,132 | $0 | EDGAR |
| 2020-06-24 | At Home Group Inc. (HOME) Delisted | Grant (A) | +16,300 | $0 | EDGAR |
| 2019-06-19 | TSCO | Mixed | −5,407 | -$1.31M | EDGAR |
| 2019-05-02 | TSCO | Mixed | −20,290 | -$2.35M | EDGAR |
| 2019-04-05 | TSCO | Mixed | — | -$894.3K | EDGAR |
| 2019-04-01 | At Home Group Inc. (HOME) Delisted | Grant (A) | +7,292 | $0 | EDGAR |
| 2019-02-22 | TSCO | Mixed | — | -$1.16M | EDGAR |
| 2019-02-08 | TSCO | Mixed | +13,468 | -$58.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.